cis-Methyl 4-((tert-butoxycarbonyl)amino)piperidine-3-carboxylate

Catalog No. :
ACLRCG653
CAS No. :
1217684-50-8
Molecular Formula :
C12H22N2O4
Molecular Weight :
258.32

IUPAC Name:methyl (3S,4R)-4-((tert-butoxycarbonyl)amino)piperidine-3-carboxylate

cis-Methyl 4-((tert-butoxycarbonyl)amino)piperidine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$147.00Login to see priceIn stockInquiry
250mg95%$232.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-Methyl 4-((tert-butoxycarbonyl)amino)piperidine-3-carboxylate
IUPAC Namemethyl (3S,4R)-4-((tert-butoxycarbonyl)amino)piperidine-3-carboxylate
MDL No.MFCD09991633
Molecular FormulaC12H22N2O4
Molecular Weight258.32
SMILESO=C([C@H]1CNCC[C@H]1NC(OC(C)(C)C)=O)OC
InChI KeyJZMRLHYTQICGLN-DTWKUNHWSA-N
Synonymcis-4-Boc-aMino-piperidine-3-carboxylic acidMethyl ester;3-Piperidinecarboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (3R,4S)-rel-;cis-Methyl 4-((tert-butoxycarbonyl)amino)piperidine-3-carboxylate;methyl (3S,4R)-4-((tert-butoxycarbonyl)amino)piperidine-3-carboxylate;Methyl cis-4-(Boc-amino)piperidine-3-carboxylate
CAS No.1217684-50-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLRCG653 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLRCG653 route product structure diagram
    ACLRCG6531217684-50-8 In Stock
Inquiry

2. ACLRCG653 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLRCG653 route product structure diagram
    ACLRCG6531217684-50-8 In Stock
Inquiry

Comments (0)